1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PepsiCo, Inc.
  6. Summary
    PEP   US7134481081

PEPSICO, INC.

(PEP)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
177.33 USD   +1.31%
08/12Frito-Lay Invests $500,000 in Scholarship Program with the United Negro College Fund to Provide College Education for Black and Hispanic Students
PR
08/11Coca-Cola HBC flags one-time $195 million hit from Russian operations
RE
08/09Musk sells Tesla stock worth $6.9 bln as possibility of forced Twitter deal rises
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
173.85(c) 174.5(c) 175.94(c) 175.04(c) 177.33(c) Last
2 846 584 3 228 826 4 041 101 2 743 920 3 756 404 Volume
-0.40% +0.37% +0.83% -0.51% +1.31% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 83 572 M - -
Net income 2022 10 812 M - -
Net Debt 2022 31 149 M - -
P/E ratio 2022 23,0x
Yield 2022 2,53%
Sales 2023 86 772 M - -
Net income 2023 9 790 M - -
Net Debt 2023 30 658 M - -
P/E ratio 2023 25,0x
Yield 2023 2,67%
Capitalization 245 B 245 B -
EV / Sales 2022 3,30x
EV / Sales 2023 3,17x
Nbr of Employees 309 000
Free-Float 73,9%
More Financials
Company
PepsiCo, Inc. is one of the worldwide leaders in producing non-alcoholic beverages and snacks. Net sales break down by area of activity as follows: - North America (59.9%): sale of beverages (53.1% of net sales; sodas, concentrated juices, water, tea and coffee-based beverages; Aquafina, Diet Mountain Dew, Diet Pepsi, Gatorade, Gatorade Zero, Mountain Dew, Pepsi, Propel brands, etc.), snacks (41.2%; chips,... 
More about the company
Ratings of PepsiCo, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PEPSICO, INC.
08/12Frito-Lay Invests $500,000 in Scholarship Program with the United Negro College Fund to..
PR
08/11Coca-Cola HBC flags one-time $195 million hit from Russian operations
RE
08/09Musk sells Tesla stock worth $6.9 bln as possibility of forced Twitter deal rises
RE
08/09Lay's® mashes up snack aisle with newest batch of flavor swap releases
PR
08/09Lay's Announces New Flavors
CI
08/04EUROPEAN MIDDAY BRIEFING : Stocks Gain on -2-
DJ
08/03Exxon in talks with unnamed party for Sakhalin-1 transition
RE
08/03Russian drinks maker eyes its chance as Coke exits
RE
08/03Deutsche Bank Adjusts PepsiCo's Price Target to $179 From $178, Maintains Hold Rating
MT
08/03Exclusive-Russian soft drinks maker targets 50% of market to fill gap left by Coke, Pep..
RE
08/02Frito-lay variety packs back-to-school program inspires 1 million more girls to pursue ..
PR
08/02PepsiCo to Acquire 20% of Romania's Aqua Carpatica
MT
08/02PepsiCo To Acquire 20% Stake In Romania's AQUA Carpatica
MT
08/02PepsiCo and AQUA Carpatica Announce Strategic Relationship
PR
08/02PepsiCo, Inc. Enters into Strategic Agreement with Aqua Carpatica
CI
More news
News in other languages on PEPSICO, INC.
08/11Coca-Cola HBC annonce une perte unique de 195 millions de dollars pour ses activités en..
08/09Lay's annonce de nouveaux parfums
08/05Publicis Groupe, plus forte baisse du CAC 40 à la mi-séance du vendredi 5 août 2022 –
08/03Russischer Limonadenhersteller will Coca-Cola und Pepsi beerben
08/03Exclusif-Russie-Le fabricant de sodas Chernogolovka vise 50% du marché après le départ ..
More news
Analyst Recommendations on PEPSICO, INC.
More recommendations
Chart PEPSICO, INC.
Duration : Period :
PepsiCo, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PEPSICO, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 177,33 $
Average target price 181,00 $
Spread / Average Target 2,07%
EPS Revisions
Managers and Directors
Ramon Luis Laguarta Vice President-Business Development
Hugh F. Johnston President-Pepsi-Cola North America
Rene Lammers Chief Science Officer & Executive Vice President
Seth Cohen Chief Information Officer & Senior Vice President
Pietro Antonio Tataranni Chief Medical Officer & Senior VP-Life Sciences
Sector and Competitors